title: Predicting medication noncompliance after hospital discharge among patients with schizophrenia.
abstract: OBJECTIVE
  The study sought to identify predictors of noncompliance with medication in a cohort of patients with schizophrenia after discharge from acute hospitalization.
  
  
  METHODS
  Adult psychiatric inpatients with schizophrenia or schizoaffective disorder for whom oral antipsychotics were prescribed (N=213) were evaluated at hospital discharge and three months later to assess medication compliance. Comparisons were made between patients who reported stopping their medications for one week or longer and patients who reported more continuous medication use.
  
  
  RESULTS
  Of the 213 patients, about a fifth (19.2 percent) met the criterion for noncompliance. Medication noncompliance was significantly associated with an increased risk of rehospitalization, emergency room visits, homelessness, and symptom exacerbation. Compared with the compliant group, the noncompliant group was significantly more likely to have a history of medication noncompliance, substance abuse or dependence, and difficulty recognizing their own symptoms. Patients who became medication noncompliant were significantly less likely to have formed a good therapeutic alliance during hospitalization as measured by inpatient staff reports and were more likely to have family members who refused to become involved in their treatment.
  
  
  CONCLUSIONS
  Patients with schizophrenia at high risk for medication noncompliance after acute hospitalization are characterized by a history of medication noncompliance, recent substance use, difficulty recognizing their own symptoms, a weak alliance with inpatient staff, and family who refuse to become involved in inpatient treatment.
authors.affiliation: Institute of Health, Health Care Policy, and Aging Research at Rutgers University in New Brunswick, New Jersey, USA. olfsonm@child.cpmc.columbia.edu
authors.forename: M
authors.initials: M
authors.lastname: Olfson
authors.forename: D
authors.initials: D
authors.lastname: Mechanic
authors.forename: S
authors.initials: S
authors.lastname: Hansell
authors.forename: C A
authors.initials: CA
authors.lastname: Boyer
authors.forename: J
authors.initials: J
authors.lastname: Walkup
authors.forename: P J
authors.initials: PJ
authors.lastname: Weiden
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006769:Hospitals, General / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D008875:Middle Aged; D009519:New York City; D010349:Patient Compliance / Q000523:psychology / Q000706:statistics & numerical data; D010351:Patient Discharge; D012307:Risk Factors; D012559:Schizophrenia / Q000188:drug therapy* / Q000534:rehabilitation; D055502:Secondary Prevention; D012720:Severity of Illness Index; D012944:Social Support; D019966:Substance-Related Disorders / Q000523:psychology; D016312:Treatment Refusal / Q000523:psychology* / Q000706:statistics & numerical data
chemical_list: D014150:Antipsychotic Agents